Mutagenesis and carcinogenesis induced by dibenzo[a,l]pyrene in the mouse oral cavity: A potential new model for oral cancer

Joseph Guttenplan, Wieslawa Kosinska, Zhong Lin Zhao, Kun Ming Chen, Cesar Aliaga, Joseph Deltondo, Timothy Cooper, Yuan Wan Sun, Shang Min Zhang, Kun Jiang, Richard Bruggeman, Arun K. Sharma, Shantu Amin, Kwangmi Ahn, Karam El-Bayoumy

Research output: Contribution to journalArticle

Abstract

Cancer of the oral cavity is a serious disease, affecting about 30,000 individuals in US annually. There are several animal models of oral cancer, but each has certain disadvantages. As a new model, we investigated whether topical application of the tobacco smoke carcinogen, dibenzo[a,l]pyrene (DB[a,l]P) is mutagenic and carcinogenic in the oral cavity of the B6C3F1 lacI and B6C3F1 mouse, respectively. B6C3F1 lacI mice received DB[a,l]P (0, 3, 6, 12 nmol) 3× per week. B6C3F1 mice received the same doses and also 24 nmol. At 38 weeks mutagenesis was measured in oral tissues in lacI mice. For the high dose group, the mutant fraction (MF) in upper mucosa and tongue increased about twofold relative to that in vehicle-alone. The increases were statistically significant. The mutational profile in the DB[a,l]P-induced mutants was compared with that induced by benzo[a]pyrene (BaP) in oral tissue. BaP is mutagenic in many tissues when administered by gavage. The mutational profile for DB[a,l]P was more similar to that reported for p53 mutations in head and neck cancers than was that of BaP. At 47 weeks, oral squamous cell carcinomas (OSCC) were found in 31% of the high-dose B6C3F1 group. Elevations of p53 and COX-2 protein were observed in tumor and dysplastic tissue. As DB[a,l]P induces mutations and tumors in the oral cavity, and has a mutational profile in oral tissue similar to that found in p53 in human OSCC, the treatment protocol described here may represent a new and relevant model for cancer of the oral cavity.

Original languageEnglish (US)
Pages (from-to)2783-2790
Number of pages8
JournalInternational Journal of Cancer
Volume130
Issue number12
DOIs
StatePublished - Jun 15 2012

Fingerprint

Mouth Neoplasms
Mutagenesis
Mouth
Carcinogenesis
Squamous Cell Carcinoma
Mutation
Benzo(a)pyrene
Head and Neck Neoplasms
Clinical Protocols
Tongue
Smoke
Carcinogens
Tobacco
Neoplasms
Mucous Membrane
Animal Models
dibenzo(a,l)pyrene
Proteins

Keywords

  • DB[a,l]P
  • mutagenesis
  • mutational profile
  • oral cancer
  • tobacco smoking

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Mutagenesis and carcinogenesis induced by dibenzo[a,l]pyrene in the mouse oral cavity : A potential new model for oral cancer. / Guttenplan, Joseph; Kosinska, Wieslawa; Zhao, Zhong Lin; Chen, Kun Ming; Aliaga, Cesar; Deltondo, Joseph; Cooper, Timothy; Sun, Yuan Wan; Zhang, Shang Min; Jiang, Kun; Bruggeman, Richard; Sharma, Arun K.; Amin, Shantu; Ahn, Kwangmi; El-Bayoumy, Karam.

In: International Journal of Cancer, Vol. 130, No. 12, 15.06.2012, p. 2783-2790.

Research output: Contribution to journalArticle

Guttenplan, J, Kosinska, W, Zhao, ZL, Chen, KM, Aliaga, C, Deltondo, J, Cooper, T, Sun, YW, Zhang, SM, Jiang, K, Bruggeman, R, Sharma, AK, Amin, S, Ahn, K & El-Bayoumy, K 2012, 'Mutagenesis and carcinogenesis induced by dibenzo[a,l]pyrene in the mouse oral cavity: A potential new model for oral cancer', International Journal of Cancer, vol. 130, no. 12, pp. 2783-2790. https://doi.org/10.1002/ijc.26344
Guttenplan, Joseph ; Kosinska, Wieslawa ; Zhao, Zhong Lin ; Chen, Kun Ming ; Aliaga, Cesar ; Deltondo, Joseph ; Cooper, Timothy ; Sun, Yuan Wan ; Zhang, Shang Min ; Jiang, Kun ; Bruggeman, Richard ; Sharma, Arun K. ; Amin, Shantu ; Ahn, Kwangmi ; El-Bayoumy, Karam. / Mutagenesis and carcinogenesis induced by dibenzo[a,l]pyrene in the mouse oral cavity : A potential new model for oral cancer. In: International Journal of Cancer. 2012 ; Vol. 130, No. 12. pp. 2783-2790.
@article{2e22e28e80b54880bd0a154875a62cbd,
title = "Mutagenesis and carcinogenesis induced by dibenzo[a,l]pyrene in the mouse oral cavity: A potential new model for oral cancer",
abstract = "Cancer of the oral cavity is a serious disease, affecting about 30,000 individuals in US annually. There are several animal models of oral cancer, but each has certain disadvantages. As a new model, we investigated whether topical application of the tobacco smoke carcinogen, dibenzo[a,l]pyrene (DB[a,l]P) is mutagenic and carcinogenic in the oral cavity of the B6C3F1 lacI and B6C3F1 mouse, respectively. B6C3F1 lacI mice received DB[a,l]P (0, 3, 6, 12 nmol) 3× per week. B6C3F1 mice received the same doses and also 24 nmol. At 38 weeks mutagenesis was measured in oral tissues in lacI mice. For the high dose group, the mutant fraction (MF) in upper mucosa and tongue increased about twofold relative to that in vehicle-alone. The increases were statistically significant. The mutational profile in the DB[a,l]P-induced mutants was compared with that induced by benzo[a]pyrene (BaP) in oral tissue. BaP is mutagenic in many tissues when administered by gavage. The mutational profile for DB[a,l]P was more similar to that reported for p53 mutations in head and neck cancers than was that of BaP. At 47 weeks, oral squamous cell carcinomas (OSCC) were found in 31{\%} of the high-dose B6C3F1 group. Elevations of p53 and COX-2 protein were observed in tumor and dysplastic tissue. As DB[a,l]P induces mutations and tumors in the oral cavity, and has a mutational profile in oral tissue similar to that found in p53 in human OSCC, the treatment protocol described here may represent a new and relevant model for cancer of the oral cavity.",
keywords = "DB[a,l]P, mutagenesis, mutational profile, oral cancer, tobacco smoking",
author = "Joseph Guttenplan and Wieslawa Kosinska and Zhao, {Zhong Lin} and Chen, {Kun Ming} and Cesar Aliaga and Joseph Deltondo and Timothy Cooper and Sun, {Yuan Wan} and Zhang, {Shang Min} and Kun Jiang and Richard Bruggeman and Sharma, {Arun K.} and Shantu Amin and Kwangmi Ahn and Karam El-Bayoumy",
year = "2012",
month = "6",
day = "15",
doi = "10.1002/ijc.26344",
language = "English (US)",
volume = "130",
pages = "2783--2790",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "12",

}

TY - JOUR

T1 - Mutagenesis and carcinogenesis induced by dibenzo[a,l]pyrene in the mouse oral cavity

T2 - A potential new model for oral cancer

AU - Guttenplan, Joseph

AU - Kosinska, Wieslawa

AU - Zhao, Zhong Lin

AU - Chen, Kun Ming

AU - Aliaga, Cesar

AU - Deltondo, Joseph

AU - Cooper, Timothy

AU - Sun, Yuan Wan

AU - Zhang, Shang Min

AU - Jiang, Kun

AU - Bruggeman, Richard

AU - Sharma, Arun K.

AU - Amin, Shantu

AU - Ahn, Kwangmi

AU - El-Bayoumy, Karam

PY - 2012/6/15

Y1 - 2012/6/15

N2 - Cancer of the oral cavity is a serious disease, affecting about 30,000 individuals in US annually. There are several animal models of oral cancer, but each has certain disadvantages. As a new model, we investigated whether topical application of the tobacco smoke carcinogen, dibenzo[a,l]pyrene (DB[a,l]P) is mutagenic and carcinogenic in the oral cavity of the B6C3F1 lacI and B6C3F1 mouse, respectively. B6C3F1 lacI mice received DB[a,l]P (0, 3, 6, 12 nmol) 3× per week. B6C3F1 mice received the same doses and also 24 nmol. At 38 weeks mutagenesis was measured in oral tissues in lacI mice. For the high dose group, the mutant fraction (MF) in upper mucosa and tongue increased about twofold relative to that in vehicle-alone. The increases were statistically significant. The mutational profile in the DB[a,l]P-induced mutants was compared with that induced by benzo[a]pyrene (BaP) in oral tissue. BaP is mutagenic in many tissues when administered by gavage. The mutational profile for DB[a,l]P was more similar to that reported for p53 mutations in head and neck cancers than was that of BaP. At 47 weeks, oral squamous cell carcinomas (OSCC) were found in 31% of the high-dose B6C3F1 group. Elevations of p53 and COX-2 protein were observed in tumor and dysplastic tissue. As DB[a,l]P induces mutations and tumors in the oral cavity, and has a mutational profile in oral tissue similar to that found in p53 in human OSCC, the treatment protocol described here may represent a new and relevant model for cancer of the oral cavity.

AB - Cancer of the oral cavity is a serious disease, affecting about 30,000 individuals in US annually. There are several animal models of oral cancer, but each has certain disadvantages. As a new model, we investigated whether topical application of the tobacco smoke carcinogen, dibenzo[a,l]pyrene (DB[a,l]P) is mutagenic and carcinogenic in the oral cavity of the B6C3F1 lacI and B6C3F1 mouse, respectively. B6C3F1 lacI mice received DB[a,l]P (0, 3, 6, 12 nmol) 3× per week. B6C3F1 mice received the same doses and also 24 nmol. At 38 weeks mutagenesis was measured in oral tissues in lacI mice. For the high dose group, the mutant fraction (MF) in upper mucosa and tongue increased about twofold relative to that in vehicle-alone. The increases were statistically significant. The mutational profile in the DB[a,l]P-induced mutants was compared with that induced by benzo[a]pyrene (BaP) in oral tissue. BaP is mutagenic in many tissues when administered by gavage. The mutational profile for DB[a,l]P was more similar to that reported for p53 mutations in head and neck cancers than was that of BaP. At 47 weeks, oral squamous cell carcinomas (OSCC) were found in 31% of the high-dose B6C3F1 group. Elevations of p53 and COX-2 protein were observed in tumor and dysplastic tissue. As DB[a,l]P induces mutations and tumors in the oral cavity, and has a mutational profile in oral tissue similar to that found in p53 in human OSCC, the treatment protocol described here may represent a new and relevant model for cancer of the oral cavity.

KW - DB[a,l]P

KW - mutagenesis

KW - mutational profile

KW - oral cancer

KW - tobacco smoking

UR - http://www.scopus.com/inward/record.url?scp=84859926483&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859926483&partnerID=8YFLogxK

U2 - 10.1002/ijc.26344

DO - 10.1002/ijc.26344

M3 - Article

VL - 130

SP - 2783

EP - 2790

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 12

ER -